Continuous glucose monitoring continues to show promise: studies

NEW YORK (Reuters Health) – Continuous glucose monitoring (CGM) improved diabetes control and reduced glucose variability and was well liked in two studies of patients with type 1 diabetes using multiple daily insulin injections.